6:14

Behind the Bell: Applied Therapeutics

4:23

SORD Deficiency Explained

1:02:48

The drug development process Govorestat and the INSPIRE clinical trial for CMT SORD

5:19

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

5:42

Efficacy of Govorestat to Treat Galactemia

3:52

Applied Therapeutics - Diabetic Cardiomyopathy: An Opportunity for Clinical Intervention

7:38

Introduction to Pharmacology

16:20

Regular People V Olympic Rower | Brutal Challenge